Expert insights. Personalized for you.
Biotech Related Topics 
McKinsey
MAY 11, 2022
Biotech stocks have taken a hit, but the sector will probably rebound. Companies can navigate the downturn by scrutinizing cash management and financing and rethinking paths to long-term value creation. Insights on Life Sciences Health Care Biotechnology
McKinsey
JANUARY 29, 2021
An emerging model for biotech companies could disrupt the R&D landscape and open up new ways to invest, motivate teams, and shape the innovation pipeline.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
McKinsey
JUNE 10, 2022
From 2019 to 2021, venture capitalists plowed $35 billion into biotech companies with advanced platform technologies that could transform the industry.
McKinsey
DECEMBER 3, 2021
The United Kingdom is Europe’s leading biotech hub in breakthrough life-sciences start-ups. How is this hub maturing relative to its global peers, and what lies ahead on the road to sustainable scale? Insights on Life Sciences Pharmaceuticals Medical products United Kingdom
McKinsey
MARCH 23, 2022
Establishing an international presence with a first launch is a challenge, but learning from others’ experiences can help biotechs avoid missteps and maximize their chances of success.
McKinsey
JUNE 29, 2021
World-class science and innovation need to be matched with stronger scale-up capabilities and a broader funding base if Europe is to emerge as a leader in biotech.
McKinsey
JUNE 9, 2022
Emerging biotechnology companies are less satisfied than large pharmaceutical companies with their contract research organizations (CROs). How can CROs raise their game with this key segment? Insights on Life Sciences Biotechnology
Planview Blog
JANUARY 27, 2022
Today we’re going to look at how a global biotech company used biotech project management software to drive greater business value. Senior Director of IT Governance, Global Biotech Company. ” Senior Director of IT Governance, Global Biotech Company.
Frost & Sullivan
JULY 22, 2021
As a result, academic labs and small biotech companies are accelerating RNA therapeutics research, alongside Tier 1 biopharmaceutical companies.”
McKinsey
AUGUST 23, 2021
Europe may be catching up with the United States in biotech innovation and funding. Its overall score on the Biotech Innovation Index improved by 20 percent in 2015–17 and 2018–20. Insights on Pharmaceuticals & Medical Products Biotechnology Europe
McKinsey
JULY 29, 2021
We mapped out 1,382 biotechs based in Europe and some interesting themes emerged. Insights on Pharmaceuticals & Medical Products Biotechnology
Frost & Sullivan
OCTOBER 14, 2021
About Evaxion Biotech A/S (Evaxion). Evaxion Biotech A/S is a clinical-stage AI-immunology™ platform company decoding the human immune system to discover and develop novel immunotherapies to treat cancer, and vaccines against bacterial diseases and viral infections.
McKinsey
AUGUST 26, 2021
How can biotechs and investors succeed in the future? To scale up innovation, industry stakeholders need to focus on several key areas. Insights on Pharmaceuticals & Medical Products Biotechnology
McKinsey
SEPTEMBER 15, 2021
How can biotechs and investors succeed in the future? To scale up innovation, industry stakeholders need to focus on several key areas. Insights on Life Sciences Biotechnology
McKinsey
AUGUST 23, 2021
Europe’s biotech sector has made meaningful progress in attracting capital. However, raising more capital will be essential to the continued growth of this sector. Insights on Pharmaceuticals & Medical Products Biotechnology Europe
McKinsey
FEBRUARY 9, 2021
How a biotech scientist helped transform a traditional science organization into an innovation leader. Strategy & Corporate Finance Insights
McKinsey
AUGUST 5, 2021
Europe is a powerhouse in scientific publishing with roughly twice the output of the United States and three times that of China. Insights on Pharmaceuticals & Medical Products Biotechnology Europe
LaVoie Health Science Blog
NOVEMBER 19, 2020
Donna discusses what makes strategic communications and investor relations in biotech different from other industries. The communications function is often reliant on the entire strategic leadership team in a startup biotech.
Peter Simoons
FEBRUARY 28, 2021
This is what we most often see in pharma and biotech alliances. Last week I was asked a question about where would be the best location for an alliance & partnerships team in an organisation for reporting purposes.
LaVoie Health Science Blog
OCTOBER 5, 2020
Knowledge and understanding of what drives value for biotech, platform and product companies in health as well as knowledge of the specialist investors, banks, analysts. Seeking an individual that wants to join a growing team of health and science communications experts to drive investor targeting and outreach as well as handling of investor meetings with senior management at client companies. Track investor outreach, report and guide on next steps based on feedback.
Frost & Sullivan Manufacturing
JULY 19, 2022
The company provides a life science research e-commerce platform that handles purchasing transactions for suppliers and buyers, including world-renowned academic and government research facilities and global pharmaceutical and biotech companies. SAN ANTONIO, TX.
LaVoie Health Science Blog
JULY 5, 2022
DL: As an integrated communications agency serving the biotech, pharmaceutical, and affiliated health and science industry for over 20 years , we developed specific guidance for clients on how to develop and deliver highly effective corporate presentations.
LaVoie Health Science Blog
SEPTEMBER 3, 2020
At the same time, the biotech and pharmaceutical industries are in the spotlight as never before as nations and companies push programs to try to develop vaccines and therapeutics for the virus faster than drugs have ever been created before.
LaVoie Health Science Blog
JUNE 21, 2022
GB: Donna Lavoie founded her integrated communications agency almost 22 years ago in the firm conviction that biotech and health sciences companies are best served having their public, media, and investor relations all under one roof, from seed-stage to corporate adulthood.
LaVoie Health Science Blog
AUGUST 3, 2020
LaVoieHealthScience interns work with an innovative account team on key pharma and biotech accounts as well as assisting with agency marketing efforts. Our interns grow professionally through exposure to a wide range of corporate marketing and communications, media relations and investor relations accounts and projects.
LaVoie Health Science Blog
JULY 16, 2021
As investments into sustainable companies and funds have surged to new highs, how can biotech and life science companies best position themselves with this burgeoning group of investors. Interviews with our senior practice managers about issues of important to life science innovators.
LaVoie Health Science Blog
JANUARY 11, 2021
The ideal experience is in Biotech, Pharma, Device, MedTech, Public Health & Wellness and will contribute to agency revenue growth by retaining and organically growing the existing portfolio of clients, as well as leveraging his/her relationships and deep experience as a healthcare industry leader, to attract new clients through relationship cultivation and network development.
LaVoie Health Science Blog
OCTOBER 14, 2020
Wainwright has announced their “Bioconnect” event will be held virtually during the same week as JPM, and the Biotech Showcase, traditionally held at the Hilton in San Francisco, is piloting a new virtual format with advance access for participants beginning as early as this November.
LaVoie Health Science Blog
JULY 13, 2022
LaVoie , President and CEO, said “Our LHS Immersion process and The LHS Fifteen-Slide Presentation approach are foundational elements of the fully individualized communications services we provide to help our biotech, pharma, and health science clients uncover and pursue optimal strategies to reach their business goals. Proprietary Message & Positioning Platform Defines Narrative for Health & Science Innovators.
COO Alliance
MAY 30, 2021
Our guest today is COO Alliance Member, Dana Berg the COO of SADA Systems. . As Chief Operating Officer, Dana Berg is driven by the singular mission of identifying and implementing innovative solutions that create competitive advantages for our customers.
CoSell
JANUARY 14, 2021
Just a few days ago, Pfizer and Biotech announced they are making headway on a vaccine that could be released by spring. As business leaders, we’re always on the lookout for success insights.
Frost & Sullivan
MARCH 14, 2022
It provides blood safety, clinical chemistry, companion diagnostics, custom biotech, laboratory automation and software solutions, and molecular diagnostics services. Roche is the world’s largest biotech company.
Partnership on AI
AUGUST 2, 2019
Watch the webinar as the assembled team of experts discuss cut through common misconceptions and highlight findings from case studies featuring three different organizations integrating AI from three different sectors (Steel, Retail Banking, and Biotech). What are the real-world impacts of AI on labor and the economy?
LaVoie Health Science Blog
FEBRUARY 17, 2022
LaVoieHealthScience interns work with an innovative account team on key pharma and biotech accounts as well as assisting with agency marketing efforts. Hybrid, Boston, Full-Time. DESCRIPTION. LaVoieHealthScience is looking for recent college graduates interested in gaining experience in public relations and marketing in the growing life science industry. Highly-qualified College seniors with relevant experience may also be considered for immediate placement.
LaVoie Health Science Blog
FEBRUARY 15, 2022
A minimum of 8-15 years of experience in life science, healthcare accounts – both biotech and pharma will be important to the role and preferred. Seeking a practice builder to sit in our Boston office in Back Bay. Successful candidate will have proven people skills, with demonstrated leadership qualities, with a strong ability to take action and make things happen. This is a role for an executive who can think big but roll up his/her sleeves.
Frost & Sullivan
MARCH 23, 2021
Based on its recent analysis of the North American market for industrial enterprise performance management, Frost & Sullivan recognizes Pharmactive Biotech Products, S.L. About Pharmactive Biotech Products, S.L. Pharmactive Biotech Products, S.L.,
LaVoie Health Science Blog
NOVEMBER 30, 2021
With a mixture of meetings in person and virtual, we anticipate that the cadence of meetings will be more efficient with JP Morgan and the Biotech Showcase family of events meeting in person that week and the Needham Growth Conference and HC Wainwright Bioconnect Conferences meeting virtually.
Frost & Sullivan
APRIL 21, 2021
The expanded portfolio will help build long-term relationships with small and mid-sized pharma and biotech sponsors due to increased engagement early on in the drug development process.
Channel Insider
FEBRUARY 3, 2022
Atos is a global digital solutions company offering industry-recognized solutions for cybersecurity, digital workplaces, consulting, and managed services.
The Capital Alliance Blog
MARCH 9, 2020
It might make sense for a biotech company, for example, that is researching a new drug and needs ready access to capital. By Russell Tolander. Managing Director. Nano-capitalization public companies, those with a valuation of less than $50 million, have fewer active buyers interested in them in today’s public markets, due to existing trends such as investors’ favoritism toward large companies, technology startups and disruptive or innovative business models (think Uber, Lyft, Amazon).
84 
Let's personalize your content